10.27.15
Silk Therapeutics Inc. has been issued a Notice of Allowance for its patent application by the United States Patent and Trademark Office ("USPTO"), for its new form of pure, natural and stable silk protein.
Silk Therapeutics is a specialty biotechnology company known for its innovative silk protein product platform.
"By utilizing advanced manufacturing technology, our goal was to create a reliable source of highly pure, natural, non-GMO silk protein," said Greg Altman, PhD, Chief Executive Officer, Silk Therapeutics. "Our technology platform will form the basis for products, where silk's unique ability to treat skin as well as stabilize and deliver active ingredients without the use of harsh chemicals and solvents can be leveraged."
Silk Therapeutics intends to pursue product opportunities that will eliminate the unnecessary use of unregulated chemicals used in today's consumer products. The company further hopes to pursue partnerships with product developers interested in health based applications.
Silk Therapeutics is a specialty biotechnology company known for its innovative silk protein product platform.
"By utilizing advanced manufacturing technology, our goal was to create a reliable source of highly pure, natural, non-GMO silk protein," said Greg Altman, PhD, Chief Executive Officer, Silk Therapeutics. "Our technology platform will form the basis for products, where silk's unique ability to treat skin as well as stabilize and deliver active ingredients without the use of harsh chemicals and solvents can be leveraged."
Silk Therapeutics intends to pursue product opportunities that will eliminate the unnecessary use of unregulated chemicals used in today's consumer products. The company further hopes to pursue partnerships with product developers interested in health based applications.
